The tumor suppressor WT1 drives progenitor cell progression and epithelialization to prevent Wilms tumorigenesis in human kidney organoids - ScienceDirect
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 8 (2021)
Wilms tumor
The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol | Nature Reviews Urology
Risk Stratification for Wilms Tumor: Current Approach and Future Directions | American Society of Clinical Oncology Educational Book
Loss of heterozygosity (LOH) in Wilms' tumour. (a) An explanation of... | Download Scientific Diagram
Conditions with an increased risk of Wilms tumour | Download Table
IJMS | Free Full-Text | Identification of Apolipoprotein C-I as a Potential Wilms' Tumor Marker after Excluding Inflammatory Factors
Systematic review of the immunological landscape of Wilms tumors: Molecular Therapy - Oncolytics
Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor
Serum markers in pediatric solid tumors. | Download Table
Wilms tumor: nephroblastoma - Creative Med Doses
NEPHROBLASTOMA (WILMS TUMOR) - ppt download
Risk Stratification for Wilms Tumor: Current Approach and Future Directions | American Society of Clinical Oncology Educational Book
PDF] Biological Drivers of Wilms Tumor Prognosis and Treatment | Semantic Scholar
Wilms' tumors typically consist of three cell types that correspond to... | Download Scientific Diagram
Frontiers | MicroRNA Profiling in Wilms Tumor: Identification of Potential Biomarkers
Frontiers | Biomarkers for patients with Wilms tumor: a review
Podocyte lineage marker expression is preserved across Wilms tumor subtypes and enhanced in tumors harboring the SIX1/2-Q177R mutation | bioRxiv